Company Profile - UroGen Pharma Ltd

Introduction

UroGen Pharma Ltd (UroGen Pharma), formerly TheraCoat Ltd, is a biopharmaceutical company that develops novel medicines to treat cancer indications and urologic diseases. The company products include Jelmyto is a drug formulation of mitomycin used to treat low-grade upper tract urothelial cancer. Its pipeline products include UGN-102 is a mitomycin gel is used to treat low-grade intermediate risk non-muscle invasive bladder cancer; UGN-201 and UGN-302 targets high-grade non-muscle invasive bladder cancer and Botox or RTgel for the treatment of overactive bladder. Urogen Pharma designed RTGel a reverse-thermal hydrogel technology platform to facilitate intracavitary treatment of urological conditions. The company works in collaboration with Allergan and Janssen pharmaceuticals to advance its pipeline products. UroGen Pharma is headquartered in Princeton, New Jersey, the US.